|
Sign In to gain access to subscriptions and/or personal tools.
|
Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia
Hideki Hosojima
Psychiatric Center, Yokohama City University Medical Center, Yokohama, Japan and Department of Psychiatry, Yokohama City University School of Medicine, Yokohama, Japan
Takashi Togo
Department of Psychiatry, Yokohama City University School of Medicine, Yokohama, Japan and Yokohama Maioka Hospital, Yokohama, Japan, togo-t{at}rd6.so-net.ne.jp
Toshinari Odawara
Psychiatric Center, Yokohama City University Medical Center, Yokohama, Japan and Department of Psychiatry, Yokohama City University School of Medicine, Yokohama, Japan
Koichi Hasegawa
Radioisotope Research Center, Yokohama City University School of Medicine, Yokohama, Japan
Satoshi Miura
Radioisotope Research Center, Yokohama City University School of Medicine, Yokohama, Japan
Yuiko Kato
Psychiatric Center, Yokohama City University Medical Center, Yokohama, Japan and Department of Psychiatry, Yokohama City University School of Medicine, Yokohama, Japan
Akiko Kanai
Psychiatric Center, Yokohama City University Medical Center, Yokohama, Japan and Department of Psychiatry, Yokohama City University School of Medicine, Yokohama, Japan
Akihiko Kase
Yokohama Maioka Hospital, Yokohama, Japan
Hirotake Uchikado
Department of Psychiatry, Yokohama City University School of Medicine, Yokohama, Japan
Yoshio Hirayasu
Department of Psychiatry, Yokohama City University School of Medicine, Yokohama, Japan, hirayasu{at}med.yokohama-cu.ac.jp
Although treatment with antipsychotics, particularly olanzapine and clozapine, has been implicated in weight gain and higher incidence of diabetes, the mechanism of these adverse reactions remains unclear. The purposes of this study were to explore the early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin, three recently identified hormones that play crucial roles in the regulation of energy balance and glucose metabolism. Thirteen patients with schizophrenia who had not received any medication in the 4 weeks prior to this study were included. The patients received olanzapine at an average dose of 14.5mg/day. Serum levels of ghrelin, adiponectin, leptin and insulin, as well as weight and fasting glucose, were investigated at the baseline and at 4 weeks. Serum ghrelin levels had decreased (p 0.03) and leptin had increased (p 0.02), while adiponectin and insulin levels had not significantly changed at Week 4 (p 0.29 and p 0.25, respectively). Weight had increased (p 0.01), while fasting glucose had not significantly changed (p 0.46). These findings suggest that ghrelin levels decrease and leptin levels increase after initiation of olanzapine therapy. Weight gain is also considered to be an early change, while change in insulin sensitivity is not an early change of treatment with olanzapine. Further large-scale and longitudinal studies are warranted to elucidate metabolic changes involving ghrelin, adiponectin, leptin and insulin and their impact on weight and glucose metabolism during treatment with olanzapine and other antipsychotics.
Key Words: olanzapine • schizophrenia • weight gain • diabetes • ghrelin • adiponectin • leptin
References
- Allison D B, Mentore J L, Heo M, Chandler L P, Cappelleri J C, Infante M C, Weiden P J (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis . Am J Psychiatry 156: 1686-1696 [Abstract/Free Full Text]
- American Diabetes Association (2004) Diagnosis and classification of diabetes mellitus . Diabetes Care 27 (Suppl. 1): S5-S10
- Atmaca M, Kuloglu M, Tezcan E, Ustundag B (2003) Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics . J Clin Psychiatry 64: 598-604 [Web of Science][Medline]
[Order article via Infotrieve]
- Bromel T, Blum W F, Ziegler A, Schulz E, Bender M, Fleischhaker C, Remschmidt H, Krieg J C, Hebebrand J (1998) Serum leptin levels increase rapidly after initiation of clozapine therapy . Mol Psychiatry 3: 76-80 [CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Cooper G D, Pickavance L C, Wilding J P, Halford J C, Goudie A J (2005) A parametric analysis of olanzapine-induced weight gain in female rats . Psychopharmacology (Berl)
- Cummings D E, Purnell J Q, Frayo R S, Schmidova K, Wisse B E, Weigle D S (2001) A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans . Diabetes 50: 1714-1719 [Abstract/Free Full Text]
- Graham K A, Perkins D O, Edwards L J, Barrier Jr R C, Lieberman J A, Harp J B (2005) Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis . Am J Psychiatry 162: 118-123 [Abstract/Free Full Text]
- Henderson D C, Cagliero E, Copeland P M, Borba C P, Evins E, Hayden D, Weber M T, Anderson E J, Allison D B, Daley T B, Schoenfeld D, Goff D C (2005) Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis . Arch Gen Psychiatry 62: 19-28 [Abstract/Free Full Text]
- Herran A, Garcia-Unzueta M T, Amado J A, de La Maza M T, Alvarez C, Vazquez-Barquero J L (2001) Effects of long-term treatment with antipsychotics on serum leptin levels . Br J Psychiatry 179: 59-62 [Abstract/Free Full Text]
- Janeckova R (2001) The role of leptin in human physiology and pathophysiology . Physiol Res 50: 443-459 [Web of Science][Medline]
[Order article via Infotrieve]
- Jin H, Meyer J M, Jeste D V (2002) Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases . Ann Clin Psychiatry 14: 59-64 [CrossRef][Medline]
[Order article via Infotrieve]
- Kraus T, Haack M, Schuld A, Hinze-Selch D, Kuhn M, Uhr M, Pollmacher T (1999) Body weight and leptin plasma levels during treatment with antipsychotic drugs . Am J Psychiatry 156: 312-314 [Abstract/Free Full Text]
- Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach . Nature 402: 656-660 [CrossRef][Medline]
[Order article via Infotrieve]
- Lukoff D, Nuechterlein K H, Ventura J (1986) Manual for Expanded Brief Psychiatric Rating Scale (BPRS) . Schizophrenia Bull 12: 594-602
- Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1) . Biochem Biophys Res Commun 221: 286-289 [CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C (1985) Homeostasis model assessment: insulin resistance and [beta]-cell function from fasting plasma glucose and insulin concentrations in man . Diabetologia 28: 412-419 [CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Matsumoto M, Hosoda H, Kitajima Y, Morozumi N, Minamitake Y, Tanaka S, Matsuo H, Kojima M, Hayashi Y, Kangawa K (2001) Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides . Biochem Biophys Res Commun 287: 142-146 [CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- McIntyre R S, McCann S M, Kennedy S H (2001) Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities . Can J Psychiatry 46: 273-281 [Web of Science][Medline]
[Order article via Infotrieve]
- Melkersson K I, Dahl M L (2003) Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses . Psychopharmacology (Berl) 170(2): 157-166 [CrossRef][Medline]
[Order article via Infotrieve]
- Murashita M, Kusumi I, Inoue T, Takahashi Y, Hosoda H, Kangawa K, Koyama T (2005) Olanzapine increases plasma ghrelin level in patients with schizophrenia . Psychoneuroendocrinology 30: 106-110 [CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S (2001) A role for ghrelin in the central regulation of feeding . Nature 409: 194-198 [CrossRef][Medline]
[Order article via Infotrieve]
- Newcomer J W, Haupt D W, Fucetola R, Melson A K, Schweiger J A, Cooper B P, Selke G (2002) Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia . Arch Gen Psychiatry 59: 337-345 [Abstract/Free Full Text]
- Prolo P, Wong M L, Licinio J (1998) Leptin . Int J Biochem Cell Biol 30: 1285-1290 [CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Qi Y, Takahashi N, Hileman S M, Patel H R, Berg A H, Pajvani U B, Scherer P E, Ahima R S (2004) Adiponectin acts in the brain to decrease body weight . Nat Med 10: 524-529 [CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Scherer P E, Williams S, Fogliano M, Baldini G, Lodish H F (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes . J Biol Chem 270: 26746-26749 [Abstract/Free Full Text]
- Sernyak M J, Leslie D L, Alarcon R D, Losonczy M F, Rosenheck R (2002) Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia . Am J Psychiatry 159: 561-566 [Abstract/Free Full Text]
- Sowell M, Mukhopadhyay N, Cavazzoni P, Carlson C, Mudaliar S, Chinnapongse S, Ray A, Davis T, Breier A, Henry R R, Dananberg J (2003) Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp . J Clin Endocrinol Metab 88: 5875-5880 [Abstract/Free Full Text]
- Togo T, Hasegawa K, Miura S, Hosojima H, Kojima K, Shoji M, Kase A, Uchikado H, Iseki E, Kosaka K (2004a) Serum ghrelin concentrations in patients receiving olanzapine or risperidone . Psychopharmacology (Berl) 172: 230-232 [CrossRef][Medline]
[Order article via Infotrieve]
- Togo T, Kojima T, Shoji M, Kase A, Uchikado H, Katsuse O, Iseki E, Kosaka K (2004b) Serum adiponectin concentrations during treatment with olanzapine or risperidone: a pilot study . Int Clin Psychopharmacol 19: 37-40 [Medline]
[Order article via Infotrieve]
- Tschop M, Smiley D L, Heiman M L (2000) Ghrelin induces adiposity in rodents . Nature 407: 908-913 [CrossRef][Medline]
[Order article via Infotrieve]
- Tschop M, Wawarta R, Riepl R L, Friedrich S, Bidlingmaier M, Landgraf R, Folwaczny C (2001) Post-prandial decrease of circulating human ghrelin levels . J Endocrinol Invest 24: RC19-RC21 [Web of Science][Medline]
[Order article via Infotrieve]
- Wetterling T (2001) Bodyweight gain with atypical antipsychotics, A comparative review . Drug Saf 24: 59-73 [CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Wren A M, Seal L J, Cohen M A, Brynes A E, Frost G S, Murphy K G, Dhillo W S, Ghatei M A, Bloom S R (2001) Ghrelin enhances appetite and increases food intake in humans . J Clin Endocrinol Metab 86: 5992 [Abstract/Free Full Text]
- Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman M L, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity . Nat Med 7: 941-946 [CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Zigman J M, Elmquist J K (2003) Minireview: from anorexia to obesity - the yin and yang of body weight control . Endocrinology 144: 3749-3756 [Abstract/Free Full Text]
This version was published on January
1, 2006
Journal of Psychopharmacology, Vol. 20, No. 1,
75-79 (2006)
DOI: 10.1177/0269881105056647
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
O. Sentissi, J. Epelbaum, J.-P. Olie, and M.-F. Poirier
Leptin and Ghrelin Levels in Patients With Schizophrenia During Different Antipsychotics Treatment: A Review
Schizophr Bull,
November 1, 2008;
34(6):
1189 - 1199.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Sarandol, S. Kirli, C. Akkaya, N. Ocak, E. Eroz, and E. Sarandol
Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment
J Psychopharmacol,
November 1, 2007;
21(8):
857 - 863.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N. R. Poa and P. F. Edgar
Insulin Resistance Is Associated With Hypercortisolemia in Polynesian Patients Treated With Antipsychotic Medication
Diabetes Care,
June 1, 2007;
30(6):
1425 - 1429.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
